Intrathecal Prilocaine versus Bupivacaine for Enhanced Recovery in Patient Undergoing ambulatory arthroscopic Surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202608906353159

Enrollment

156

Registered

2026-08-14

Start date

2025-05-05

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

prilocaine

bupivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients (ASA I-II) undergoing elective ambulatory knee arthroscopic surgery of both sexes, aged (20-60years)

Exclusion criteria

Exclusion criteria: ?patient refusal ?Patient with mental incapacity precluding informed consent. ? Presence of coagulopathy. ? Infection of the skin or subcutaneous tissue in puncture area. ? Patients with preexisting neuropathology in the lower limbs. Allergy to studied drugs.

Design outcomes

Primary

Measure	Time frame
Effect on postoperative enhanced recovery measured by post anesthetic discharge score( pAD score)	—

Secondary

Measure	Time frame
?Assessment of sensory and motor block. ?Incidence of complication (hypotension, bradycardia, urine retention, local anesthetic toxicity). ?Intraoperative and postoperative hemodynamic monitoring. ?Duration of postoperative analgesia. Patient satisfaction.	—

Countries

Egypt

Contacts

Public Contactahmed hashem esmail

Lecturer of Anesthesiology

ahmed_esmil@med.menofia.edu.eg0201008999061

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026